You have 3 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HR advanced cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Thalassery, Kerala, India
    Novartis Investigative Site
Nov 21, 2022

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced

Active, not recruiting
  • Breast Cancer
    • Copenhagen, Denmark
      Danish Breast Cancer Group
    Jul 6, 2022

    Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)

    Withdrawn
    • Solid Tumor
    • Advanced Breast Cancer
    • Milwaukee, Wisconsin
      Froedtert Hospital and the Medical College of Wisconsin
    Dec 21, 2022

    Learn About Use and Effects of CDK4/6 Inhibitors in Canadian

    Active, not recruiting
    • Breast Cancer
      • Kirkland, Quebec, Canada
        Pfizer Canada
      Mar 5, 2023

      Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)

      Not yet recruiting
      • Advanced or Metastatic Breast Cancer
      • (no location specified)
      Oct 24, 2023

      Breast Tumor Female Trial (Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy)

      Not yet recruiting
      • Breast Neoplasm Female
      • Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy
      • (no location specified)
      Oct 17, 2022

      Ribociclib in Combination With Non-steroidal Aromatase

      Completed
      • Breast Cancer
      • Sao Paulo, SP, Brazil
        Novartis Investigative Site
      Nov 7, 2022

      Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

      Recruiting
      • Locally Advanced or Unresectable Metastatic Breast Cancer
      • Stage IV Breast Cancer
      • Sacituzumab Govitecan-hziy
      • +3 more
      • Marietta, Georgia
      • +1 more
      Apr 21, 2023

      Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

      Not yet recruiting
      • Breast Cancer
      • (no location specified)
      Aug 12, 2022

      Advanced HR+ HER2 Negative Breast Carcinoma Trial in Tianjin (Enituzumab injection+Abesili tablets+Anastrozole tablets)

      Recruiting
      • Advanced HR+ HER2 Negative Breast Carcinoma
      • Enituzumab injection+Abesili tablets+Anastrozole tablets
      • Tianjin, China
        Tianjin Cancer Hospital
      Apr 6, 2022

      Patterns of Advanced Breast Cancer in Poland in Real-world Data

      Recruiting
      • Breast Neoplasms
        • Warsaw, Poland
          Pfizer Polska
        Jul 26, 2022

        Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)

        Not yet recruiting
        • Locally Advanced or Metastatic Breast Cancer
        • SPH4336 Tablets
        • SPH4336 Tablets Placebo
        • Guangzhou, Guangdong, China
          Affiliated Cancer Hospital, Sun Yat-sen University
        May 8, 2023

        Advanced Breast Cancer Trial in Beijing (Dalpiciclib in combination with endocrine therapy by Physicians choice)

        Not yet recruiting
        • Advanced Breast Cancer
        • Dalpiciclib in combination with endocrine therapy by Physicians choice
        • Beijing, Beijing, China
          Cancer Hospital, Chinese Academy of Medical Sciences
        Jun 19, 2022

        Advanced Breast Cancer, Female Breast Cancer Trial in Shanghai (FCN-437c,Fulvestrant,Goserelin acetate,

        Recruiting
        • Advanced Breast Cancer
        • Female Breast Cancer
        • FCN-437c,Fulvestrant,Goserelin acetate
        • Placebo,Fulvestrant,Goserelin acetate
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Jun 30, 2022

        Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

        Not yet recruiting
        • Breast Cancer
        • Marseille, France
          Institut Paoli Calmettes
        Aug 9, 2023

        Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

        Recruiting
        • Advanced Breast Cancer
        • TQB3909 tablets
        • Changsha, Hunan, China
          Hunan Cancer Hospital
        Mar 16, 2023

        Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

        Recruiting
        • Advanced Breast Cancer
        • The combination of Dalpiciclib with physician-selected endocrine therapy
        • Chemotherapy selected by the physician
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        May 22, 2023

        Breast Tumor Female Trial in Beijing (CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou))

        Recruiting
        • Breast Neoplasm Female
        • CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou)
        • Beijing, Beijing, China
        • +1 more
        Jul 31, 2023

        Advanced Breast Cancer, Metastatic Breast Cancer Trial in Tianjin (SHR6390, famitinib)

        Recruiting
        • Advanced Breast Cancer
        • Metastatic Breast Cancer
        • Tianjin, Tianjin, China
          Breast Oncology, Tianjin Medical University Cancer Institute and
        Apr 6, 2022

        Advanced Breast Cancer, Female Breast Cancer Trial in Beijing (FCN-437c, Letrozole or anastrozole, Goserelin acetate, Placebo,

        Recruiting
        • Advanced Breast Cancer
        • Female Breast Cancer
        • FCN-437c, Letrozole or anastrozole, Goserelin acetate
        • Placebo, Letrozole or anastrozole, Goserelin acetate
        • Beijing, Beijing, China
          Cancer Hospital, Chinese Academy of Medical Sciences
        Jul 4, 2022

        Locally Advanced Breast Cancer, Hormone Receptor Positive,HER2-negative Breast Cancer Trial in Jinan (letrozole)

        Recruiting
        • Locally Advanced Breast Cancer
        • Hormone Receptor Positiveļ¼ŒHER2-negative Breast Cancer
        • Jinan, Shandong, China
          Breast Cancer Center, Shandong Cancer Hospital and Institute
        Apr 11, 2023

        Overall Survival in Japanese HR+/HER2- Advanced Breast Cancer

        Active, not recruiting
        • Breast Cancer
        • palbociclib plus letrozole
        • Chiba-shi, Chiba, Japan
        • +12 more
        Dec 15, 2022

        HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World

        Terminated
        Has Results
        • Breast Cancer
          • New York, New York
            Pfizer United States
          Jan 14, 2022

          Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)

          Not yet recruiting
          • Breast Cancer
          • (no location specified)
          Jan 30, 2023